ENZ(Delisted)
Enzo BiochemยทNYSE
--
--(--)
ENZ fundamentals
Enzo Biochem (ENZ) released its earnings on Mar 17, 2025: revenue was 7.33M (YoY 0.00%), beat estimates; EPS was -0.02 (YoY 0.00%), missed estimates.
Revenue / YoY
7.33M
0.00%
EPS / YoY
-0.02
0.00%
Report date
Mar 17, 2025
EPS
Revenue
Revenue & Expenses
ENZ has released its 2025 Q2 earnings report, with revenue of 7.33M, reflecting a YoY change of -14.25%, and net profit of -1.53M, showing a YoY change of 49.85%. The Sankey diagram below clearly presents ENZ's revenue sources and cost distribution.
Key Indicators
Enzo Biochem (ENZ) key financial stats and ratios, covering profitability, financial health, and leverage.
Enzo Biochem (ENZ)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Enzo Biochem (ENZ)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Enzo Biochem (ENZ)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Enzo Biochem (ENZ) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Enzo Biochem (ENZ) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
